Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Simple eye test spots patients at risk for postoperative cognitive dysfunction

Simple eye test spots patients at risk for postoperative cognitive dysfunction

AI model detects atrial fibrillation risk based on subtle ECG variations

AI model detects atrial fibrillation risk based on subtle ECG variations

Novel molecular link between vitamin B12 and multiple sclerosis revealed in astrocytes

Novel molecular link between vitamin B12 and multiple sclerosis revealed in astrocytes

DeepMirror launches early access programme for its intuitive molecular drug design software

DeepMirror launches early access programme for its intuitive molecular drug design software

Researchers discover next-gen lipid nanoparticles for muscle-focused mRNA delivery

Researchers discover next-gen lipid nanoparticles for muscle-focused mRNA delivery

Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution

Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution

Vanderbilt's potential schizophrenia treatment enters phase 1 clinical trials

Vanderbilt's potential schizophrenia treatment enters phase 1 clinical trials

Optibrium’s Quantum Mechanics and Machine Learning Methods Predict Routes of Drug Metabolism

Optibrium’s Quantum Mechanics and Machine Learning Methods Predict Routes of Drug Metabolism

MedUni Vienna scientists discover new pain medication with fewer side effects

MedUni Vienna scientists discover new pain medication with fewer side effects

Camena Bioscience appoints Dr. Nicola Thompson as Chair of the Board

Camena Bioscience appoints Dr. Nicola Thompson as Chair of the Board

'GREAT PLEA' system proposed for responsible use of generative AI in healthcare

'GREAT PLEA' system proposed for responsible use of generative AI in healthcare

Research uncovers stealthy strategy of SARS-CoV-2 infection

Research uncovers stealthy strategy of SARS-CoV-2 infection

Government’s £2 billion plan sets out to harness the power of engineering biology

Government’s £2 billion plan sets out to harness the power of engineering biology

The past, present and future of automation and digitalization in the life sciences laboratory

The past, present and future of automation and digitalization in the life sciences laboratory

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

UK Biobank unveils world's largest genetic data set

UK Biobank unveils world's largest genetic data set

Hevolution-AFAR New Investigator Awards expanded with $16 million grant

Hevolution-AFAR New Investigator Awards expanded with $16 million grant

New drug combination may improve treatment for rare nerve sheath tumors

New drug combination may improve treatment for rare nerve sheath tumors

Genetic evidence suggests thiazide diuretics reduce kidney stone risk

Genetic evidence suggests thiazide diuretics reduce kidney stone risk

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.